NCT04392141View on ClinicalTrials.gov

Colchicine Plus Phenolic Monoterpenes to Treat COVID-19

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

November 1, 2020

Study Completion Date

November 1, 2020

Conditions
COVID-19
Interventions
DRUG

Standard Treatment

Standard Treatment for COVID-19 based on National Recommendations

DRUG

Oral administration of Colchicine plus Herbal Phenolic Monoterpene Fractions

Colchicine plus a Herbal extraction containing a Phenolic Monoterpene Fractions will be added to standard treatment in patients with COVID-19.

Trial Locations (1)

083

Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran, Kermanshah

All Listed Sponsors
lead

Kermanshah University of Medical Sciences

OTHER

NCT04392141 - Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 | Biotech Hunter | Biotech Hunter